The Meridian

The Meridian Transaction Tracker

Life Healthcare’s disposal of Life Molecular Imaging to Lantheus Holdings

2025: Life Healthcare sold its interest in Life Molecular Imaging to NASDAQ-listed Lantheus Holdings for US$750m, key financial adviser Matt Eb (RMB); illustrative of the SA healthcare portfolio reallocation wave (with #10, #12).

2025: Life Healthcare sold its interest in Life Molecular Imaging to NASDAQ-listed Lantheus Holdings for US$750m, key financial adviser Matt Eb (RMB); illustrative of the SA healthcare portfolio reallocation wave (with #10, #12).

Value: US$750m (R14bn) (verified against public announcements).

Advisers: RMB (Life Healthcare).

Recorded by The Meridian research desk from public announcements, regulatory filings and financial press coverage. Dates and values are as publicly reported.

The Meridian Editorial Team

Andrew U. — Editorial Director | Damilare A. — Intelligence Director | Amaka Nwoye — Senior Legal Research Analyst | Salome Mensah — Market Intelligence Analyst | May Ndlovu — Editorial Researcher | K.K. Lawal — Senior Correspondent | The Meridian’s editorial team brings experience across West African legal markets, commercial law, market intelligence and structured research. Our standard is simple: evidence first, independent judgement, and analysis grounded in how legal work happens in practice.

Previous
Next

Related Posts

Powered by CookieAdmin